
HDAC3 - Wikipedia
HDAC3 is a Class I member of the histone deacetylase superfamily (comprising four classes based on function and DNA sequence homology) that is recruited to enhancers to modulate both the epigenome and nearby gene expression.
HDAC3 Gene - GeneCards | HDAC3 Protein | HDAC3 Antibody
2024年12月25日 · HDAC3 (Histone Deacetylase 3) is a Protein Coding gene. Diseases associated with HDAC3 include Lipodystrophy, Familial Partial, Type 5 and Retinoblastoma. Among its related pathways are Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants and Transcriptional Regulation by MECP2.
The role of HDAC3 and its inhibitors in regulation of ... - Nature
2023年4月18日 · In this review, we comprehensively summarize the knowledge of the relationship of HDAC3 with mitochondria function and metabolism, ROS-produced enzymes, antioxidant enzymes, and oxidative stress...
The critical roles of histone deacetylase 3 in the pathogenesis …
2021年7月23日 · Histone deacetylase 3 (HDAC3) plays a crucial role in chromatin remodeling, which, in turn, regulates gene transcription. Hence, HDAC3 has been implicated in various diseases,...
HDAC3 is critical in tumor development and therapeutic ... - AAAS
2023年3月17日 · HDAC3 is one of the main targets of histone deacetylase (HDAC) inhibitors in clinical development as cancer therapies, yet the in vivo role of HDAC3 in solid tumors is unknown. We identified a critical role for HDAC3 in Kras -mutant lung cancer.
HDAC3: A Multifaceted Modulator in Immunotherapy …
2025年2月13日 · Histone deacetylase 3 (HDAC3) has emerged as a critical epigenetic regulator in tumor progression and immune modulation, positioning it as a promising target for enhancing cancer immunotherapy.
Histone deacetylase 3 (HDAC3) inhibitors as anticancer agents ... - PubMed
2020年4月15日 · HDAC3 inhibitors are effective for the treatment of cancers, different neurodegenerative disorders, diabetes mellitus, cardiac diseases, HIV, inflammatory diseases, rheumatoid arthritis (RA), etc. Inhibition of HDAC3 metalloenzyme is a dynamic approach for drug design and discovery.
Discovery of histone deacetylase 3 (HDAC3)-specific PROTACs
We discovered XZ9002, a first-in-class HDAC3-specific PROTAC that potently degraded HDAC3. Importantly, XZ9002 is more effective to inhibit cancer cell proliferation than its proteolysis-inactive counterpart, suggesting HDAC3 degradation is a novel and promising anticancer approach.
HDAC3 in action: Expanding roles in inflammation and ... - PubMed
Histone deacetylase 3 (HDAC3), an essential chromatin-modifying protein within the histone deacetylase superfamily, exerts its transcriptional inhibitory role through enzymatic histone modification to uphold normal physiological function, growth, and development of the body.
Integrative regulation of physiology by histone deacetylase 3
2018年11月2日 · In this Review, we discuss the mechanisms by which HDAC3 regulates cell type-specific enhancers, the structure of HDAC3 and its function as part of nuclear receptor co-repressors, its enzymatic...
- 某些结果已被删除